Sparsentan in immunoglobulin A nephropathy: a profile of its use Young-A HeoConnie Kang Adis Drug Q&A 29 March 2024 Pages: 101 - 108
What is the role of pioglitazone for patients with type 2 diabetes in value-based care settings? Andrea BushTina BennyMatthew Seamon Current Opinion 28 March 2024 Pages: 131 - 136
Treating paediatric Crohn’s disease is challenging but new treatments hold promise Tina Nie Disease Management 28 March 2024 Pages: 121 - 126
Correction to: Efanesoctocog alfa in hemophilia A: a profile of its use Simon FungHannah A. Blair Correction Open access 21 March 2024 Pages: 138 - 138
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use Tina Nie Correction Open access 21 March 2024 Pages: 137 - 137
Be aware of the risks of nephrotoxicity when prescribing amoxicillin and third-generation cephalosporins Amy Zhuang-Yan Drug Reactions and Interactions 21 March 2024 Pages: 127 - 130
Treat bipolar depression with atypical antipsychotics and mood stabilisers; new therapies require further study Simon Fung Practical Issues and Updates 11 March 2024 Pages: 109 - 114
Get on top of gout with a fresh look at treatment options Caroline FentonConnie Kang Practical Issues and Updates 04 April 2024 Pages: 115 - 120
Evaluation of diclofenac utilization patterns before and after digital risk minimization intervention in outpatient settings in Montenegro Maja StankovicNemanja TurkovicNemanja Rancic Original Research Article 24 February 2024 Pages: 90 - 100
Multisite primary care led amoxicillin challenge pathway to safely remove penicillin allergy label David C. MariKelley M. HensonTaylor A. Banks Therapy in Practice 10 March 2024 Pages: 83 - 89
Administer antidepressants during pregnancy on a case-by-case basis Yvette N. LambSimon Fung Practical Issues and Updates 10 March 2024 Pages: 78 - 82
Metformin reduces the complications of gestational diabetes mellitus but its long-term effects on offspring require further study Simon Fung Practical Issues and Updates 10 March 2024 Pages: 72 - 77
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA Hannah A. Blair Adis Drug Q&A 15 March 2024 Pages: 61 - 71
Mirvetuximab soravtansine in folate receptor alpha-positive, platinum-resistant ovarian cancers: a profile of its use Simon FungYahiya Y. Syed Adis Drug Q&A 10 March 2024 Pages: 53 - 60
Pirtobrutinib in relapsed or refractory mantle cell lymphoma: a profile of its use Young-A Heo Adis Drug Q&A 27 January 2024 Pages: 45 - 52
Preferably pre-empt pathological scars, or pick from a plethora of therapies Caroline FentonYvette N. Lamb Practical Issues and Updates 08 January 2024 Pages: 22 - 26
Correction to: Tezepelumab in severe asthma: a profile of its use Yahiya Y. Syed Correction Open access 05 January 2024 Pages: 43 - 43
Platelet-rich plasma therapy for chronic cutaneous wounds stratified by etiology: a systematic review of randomized clinical trials Verónica Salgado-PachecoMontserrat Serra-MasMarta Otero-Viñas Systematic Review Open access 28 February 2024 Pages: 31 - 42
Expand the treatment horizon of premenstrual dysphoric disorder with targeted therapeutic approaches Young-A Heo Practical Issues and Updates 24 February 2024 Pages: 27 - 30
Treat borderline personality disorder with psychotherapy and concomitant psychiatric disorders with adjuvant pharmacotherapy Esther S. KimYvette N. Lamb Disease Management 24 February 2024 Pages: 17 - 21
Efanesoctocog alfa in hemophilia A: a profile of its use Simon FungHannah A. Blair Adis Drug Q&A Open access 24 February 2024 Pages: 9 - 16
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use Tina Nie Adis Drug Q&A Open access 24 February 2024 Pages: 1 - 8
Nirsevimab in the prevention of respiratory syncytial virus lower respiratory tract disease: a profile of its use Matt Shirley Adis Drug Q&A 22 December 2023 Pages: 413 - 420
The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients Elisabetta MunzoneAlessandra FabiMichelino De Laurentiis Original Research Article Open access 21 December 2023 Pages: 432 - 446
Understand the benefits and risks of intravenous methadone for perioperative and chronic cancer pain management Tina Nie Practical Issues and Updates 13 December 2023 Pages: 426 - 431
Tezepelumab in severe asthma: a profile of its use Yahiya Y. Syed Adis Drug Q&A Open access 07 December 2023 Pages: 393 - 403
Spesolimab in generalised pustular psoriasis flares: a profile of its use Tina Nie Adis Drug Q&A 02 December 2023 Pages: 404 - 412
Correction to: RBX2660 (REBYOTA®) in preventing recurrence of Clostridioides difficile infection: a profile of its use in the USA Hannah A. Blair Correction Open access 24 November 2023 Pages: 447 - 447
Manage vitiligo with a personalised approach: consider old and new treatments Nicole L. France Disease Management 24 November 2023 Pages: 421 - 425
The role of belzutifan, an inhibitor of hypoxia-inducible factor, for renal cell carcinoma in adults with Von Hippel–Lindau disease: a review Anne M. SchwartzWaddih FakhreAlan D. Kaye Review Article 21 November 2023 Pages: 388 - 392
Ublituximab in relapsing forms of multiple sclerosis: a profile of its use Hannah A. Blair Adis Drug Q&A 06 November 2023 Pages: 365 - 372
Deucravacitinib in plaque psoriasis: a profile of its use Arnold Lee Adis Drug Q&A 01 November 2023 Pages: 357 - 364
Towards intra-articular therapies for more than just symptom management in osteoarthritis Simon Fung Practical Issues and Updates 09 October 2023 Pages: 382 - 387
Manage idiopathic hypersomnia with a combination of non-pharmacological and pharmacological treatments Arnold Lee Practical Issues and Updates 03 October 2023 Pages: 378 - 381
First reports of adverse drug reactions First reports of adverse drug reactions 29 September 2023 Pages: 353 - 353
Go with your gut: targeting the microbiome for treatment of irritable bowel syndrome Simon Fung Disease Management 23 September 2023 Pages: 373 - 377
RBX2660 (REBYOTA®) in preventing recurrence of Clostridioides difficile infection: a profile of its use in the USA Hannah A. Blair Adis Drug Q&A Open access 23 September 2023 Pages: 331 - 338
Prescribe colchicine with care and be aware of colchicine drug interactions Amy Zhuang-YanConnie Kang Drug Reactions and Interactions 22 September 2023 Pages: 348 - 352
Addressing the opioid epidemic in Pakistan: urgent need for opioid stewardship and comprehensive solutions Adeel SiddiquiSunil ShresthaOmar Akhlaq Bhutta Commentary 05 September 2023 Pages: 354 - 356
Nails blue? Don’t be sad, the cause may be discoverable Arnold Lee Drug Reactions and Interactions 30 August 2023 Pages: 344 - 347
Treat functional constipation in children with conventional options first and consider alternatives if needed Tina Nie Practical Issues and Updates 28 August 2023 Pages: 339 - 343
Linzagolix in moderate to severe symptoms of uterine fibroids: a profile of its use Simon FungHannah A. Blair Adis Drug Q&A 22 August 2023 Pages: 309 - 316
Manage truncal acne and scarring the same as for facial acne, but more trunk-specific therapies are warranted Connie Kang Disease Management 18 August 2023 Pages: 324 - 329
First reports of adverse drug reactions Drug Reactions and Interactions 31 July 2023 Pages: 330 - 330
Adis Summary of Research: Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents Julia PaikZaina T. Al-Salama Adis Summary of Research 29 July 2023 Pages: 317 - 318
Consider comorbidities, concomitant medications and organ function when treating chronic urticaria in older adults Tina Nie Disease Management 27 July 2023 Pages: 319 - 323
Tapinarof cream 1% in plaque psoriasis: a profile of its use Matt Shirley Adis Drug Q&A 27 July 2023 Pages: 303 - 308
Screen for drug-induced gambling disorder in vulnerable patients receiving dopaminergic drugs Simon Fung Practical Issues and Updates 21 July 2023 Pages: 297 - 301
Manage early morning ADHD symptoms and functional impairment with treatments that are effective from awakening Tina Nie Disease Management 21 July 2023 Pages: 287 - 291